FindTrial
Sign In

Artificial Intelligence Approach to Early Detection of Breast and Cervical Cancers in Indian Patients.

To study the potential of a predictive Artificial Intelligence tool to foster early identification of symptoms and criticality in breast and cervical cancers in Indian patients. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065171
Enrollment
2400
Registered
2024-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with diagnoses of carcinoma breast and carcinoma cervix 2.Willing to give consent for enrollment in the study. 4.Able to understand Hindi or English 5.Able to communicate properly

Exclusion criteria

Exclusion criteria: 1. Unable to understand or answer a clinician-administered ESAS symptom questionnaire

Design outcomes

Primary

MeasureTime frame
To develop and pilot an AI tool and its outcome to identify critical burdens of patients with breast and cervical cancers in Indian female patients on first visit and subsequent follow up visits.Timepoint: 12 months—

Secondary

MeasureTime frame
To evaluate clinician experience with the tool and barriers and facilitators to the implementation of the tool and palliative care intervention.Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Sushma Bhatnagar

All India Institute of Medical Sciences (AIIMS)

sushmabhatnagar1@gmail.com9811326453

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026